SCHEMBL18197880

SCHEMBL18197880

O=C(O)Cc1cccc(/C=C\O)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 1/20 0.50
LTB4R Q15722 1/20 0.46
LTB4R2 Q9NPC1 1/20 0.46
KDM4E B2RXH2 2/20 0.44
ALDH1A1 P00352 1/20 0.44
PKM P14618 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
PPARG P37231 1/20 0.44
PPARA Q07869 1/20 0.44
LMNA P02545 2/20 0.43
GAA P10253 2/20 0.43
TSHR P16473 2/20 0.43
RGS12 O14924 1/20 0.43
POLB P06746 1/20 0.43
MAPT P10636 1/20 0.43
HPGD P15428 1/20 0.43
NFKB1 P19838 1/20 0.43
APEX1 P27695 1/20 0.43
THPO P40225 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4397024 0.91 AKR1B1 (0.56) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL4397023 0.91 AKR1B1 (0.56) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL10374325 0.86 LTB4R (0.59) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL8324775 0.86 LTB4R (0.59) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL4683483 0.83 PPARG (0.47) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL27840537 0.83 MMP1 (0.55) AKR1B1KDM4EALDH1A1PKMMMP1
SCHEMBL4683487 0.83 PPARG (0.47) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL2388359 0.81 AKR1B1 (0.54) AKR1B1KDM4EALDH1A1CYP1A2CYP2C19
SCHEMBL4682641 0.81 PPARG (0.46) AKR1B1LTB4RLTB4R2KDM4EALDH1A1
SCHEMBL4682644 0.81 PPARG (0.46) AKR1B1LTB4RLTB4R2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1966214-B1 TRIAZOLOPYRIDAZINES AS TYROSINE KINASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2016-11-02 EP disclosed